Wu HY - Search Results

1

Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis.

Lin P, He RQ, Huang ZG, Zhang R, Wu HY, Shi L, Li XJ, Li Q, Chen G, Yang H, He Y. Lin P, et al. Among authors: wu hy. Aging (Albany NY). 2019 Apr 15;11(7):2082-2097. doi: 10.18632/aging.101902. Aging (Albany NY). 2019. PMID: 30986203 Free PMC article.

2

A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.

Xiong DD, Qin Y, Xu WQ, He RQ, Wu HY, Wei DM, Zeng JJ, Dang YW, Chen G. Xiong DD, et al. Among authors: wu hy. Clin Drug Investig. 2018 Oct;38(10):909-925. doi: 10.1007/s40261-018-0683-8. Clin Drug Investig. 2018. PMID: 30097905

3

Survival associated alternative splicing events in diffuse large B-cell lymphoma.

Zhang R, Lin P, Yang X, He RQ, Wu HY, Dang YW, Gu YY, Peng ZG, Feng ZB, Chen G. Zhang R, et al. Among authors: wu hy. Am J Transl Res. 2018 Aug 15;10(8):2636-2647. eCollection 2018. Am J Transl Res. 2018. PMID: 30210700 Free PMC article.

4

Genomic analysis of small nucleolar RNAs identifies distinct molecular and prognostic signature in hepatocellular carcinoma.

Yang H, Lin P, Wu HY, Li HY, He Y, Dang YW, Chen G. Yang H, et al. Among authors: wu hy. Oncol Rep. 2018 Dec;40(6):3346-3358. doi: 10.3892/or.2018.6715. Epub 2018 Sep 18. Oncol Rep. 2018. PMID: 30272308

5

Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.

Gao L, He RQ, Wu HY, Zhang TT, Liang HW, Ye ZH, Li ZY, Xie TT, Shi Q, Ma J, Hu XH, Chen G. Gao L, et al. Among authors: wu hy. Cell Physiol Biochem. 2018;50(5):1964-1987. doi: 10.1159/000494875. Epub 2018 Nov 5. Cell Physiol Biochem. 2018. PMID: 30396166 Free article.

6

Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.

Hou JY, Wu HY, He RQ, Lin P, Dang YW, Chen G. Hou JY, et al. Among authors: wu hy. Pathol Res Pract. 2019 Jan;215(1):177-194. doi: 10.1016/j.prp.2018.11.006. Epub 2018 Nov 10. Pathol Res Pract. 2019. PMID: 30473171

7

Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.

Yang X, Huang WT, Wu HY, He RQ, Ma J, Liu AG, Chen G. Yang X, et al. Among authors: wu hy. Oncol Rep. 2019 Apr;41(4):2241-2253. doi: 10.3892/or.2019.7033. Epub 2019 Feb 26. Oncol Rep. 2019. PMID: 30816547 Free PMC article.

8

Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.

Wu HY, Cai KT, Ma J, Chen G, Dang YW, Lu HP, Pan SL. Wu HY, et al. Pathol Res Pract. 2019 Jul;215(7):152424. doi: 10.1016/j.prp.2019.04.016. Epub 2019 Apr 29. Pathol Res Pract. 2019. PMID: 31103408

9

Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.

Wu HY, Peng ZG, He RQ, Luo B, Ma J, Hu XH, Dang YW, Chen G, Pan SL. Wu HY, et al. Int J Oncol. 2019 Aug;55(2):425-438. doi: 10.3892/ijo.2019.4834. Epub 2019 Jun 27. Int J Oncol. 2019. PMID: 31268164 Free PMC article.

10

Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.

Xie ZC, Wu HY, Ma FC, Dang YW, Peng ZG, Zhou HF, Chen G. Xie ZC, et al. Among authors: wu hy. Am J Transl Res. 2019 Jul 15;11(7):4010-4028. eCollection 2019. Am J Transl Res. 2019. PMID: 31396315 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,911 results

Search Page

Filters